Andon Health Co Ltd is a China-based company. It is principally engaged in the research and development, manufacture and distribution of medical instruments. Its main products include a blood pressure monitor, blood glucose monitor, TENS, electrical muscle stimulator, electronic pulse massager, and a digital thermometer.
1995
n/a
Last FY Revenue $372M
Last FY EBITDA $321M
$1.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Andon Health reported revenue of $372M and EBITDA of $321M.
Andon Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Andon Health valuation multiples based on analyst estimates| NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|
| Revenue | XXX | $372M | XXX | XXX | XXX |
| Gross Profit | XXX | $263M | XXX | XXX | XXX |
| Gross Margin | XXX | 71% | XXX | XXX | XXX |
| EBITDA | XXX | $321M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 86% | XXX | XXX | XXX |
| EBIT | XXX | $101M | XXX | XXX | XXX |
| EBIT Margin | XXX | 27% | XXX | XXX | XXX |
| Net Profit | XXX | $239M | XXX | XXX | XXX |
| Net Margin | XXX | 64% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Andon Health has current market cap of CNY 19.4B (or $2.8B), and EV of CNY 10.6B (or $1.5B).
As of January 19, 2026, Andon Health's stock price is CNY 42 (or $6).
See Andon Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.5B | $2.8B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAndon Health's trades at 4.1x EV/Revenue multiple, and 4.7x EV/EBITDA.
See valuation multiples for Andon Health and 15K+ public compsAs of January 19, 2026, Andon Health has market cap of $2.8B and EV of $1.5B.
Equity research analysts estimate Andon Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Andon Health's P/E ratio is not available.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.8B | XXX | $2.8B | XXX | XXX | XXX |
| EV (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 4.7x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 15.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 11.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 11.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAndon Health's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Andon Health's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Andon Health's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Andon Health and other 15K+ public comps| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Andon Health acquired XXX companies to date.
Last acquisition by Andon Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Andon Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Andon Health founded? | Andon Health was founded in 1995. |
| Where is Andon Health headquartered? | Andon Health is headquartered in China. |
| Is Andon Health publicy listed? | Yes, Andon Health is a public company listed on SHE. |
| What is the stock symbol of Andon Health? | Andon Health trades under 002432 ticker. |
| When did Andon Health go public? | Andon Health went public in 2010. |
| Who are competitors of Andon Health? | Similar companies to Andon Health include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Andon Health? | Andon Health's current market cap is $2.8B |
| Is Andon Health profitable? | Yes, Andon Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.